PFG Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.81M Buy
+11,480
New +$1.81M 0.09% 257
2025
Q2
– Sell
-14,382
Closed -$1.17M – 790
2025
Q1
$1.17M Sell
14,382
-5,681
-28% -$508K 0.07% 304
2024
Q4
$1.81M Sell
20,063
-70,774
-78% -$6.86M 0.11% 204
2024
Q3
$8.97M Buy
90,837
+12,495
+16% +$1.23M 0.57% 42
2024
Q2
$7.26M Buy
78,342
+5,018
+7% +$450K 0.49% 48
2024
Q1
$6.96M Buy
73,324
+69,132
+1,649% +$6.41M 0.51% 46
2023
Q4
$374K Buy
4,192
+66
+2% +$4.9K 0.03% 423
2023
Q3
$301K Buy
4,126
+45
+1% +$3.6K 0.03% 456
2023
Q2
$340K Sell
4,081
-2,048
-33% -$171K 0.03% 481
2023
Q1
$467K Sell
6,129
-314
-5% -$26.1K 0.04% 398
2022
Q4
$535K Sell
6,443
-22
-0.3% -$1.78K 0.05% 342
2022
Q3
$513K Buy
6,465
+130
+2% +$11K 0.06% 317
2022
Q2
$471K Buy
6,335
+501
+9% +$37.6K 0.05% 255
2022
Q1
$524K Buy
5,834
+295
+5% +$27.2K 0.05% 259
2021
Q4
$620K Sell
5,539
-496
-8% -$59.8K 0.06% 322
2021
Q3
$759K Buy
6,035
+804
+15% +$104K 0.08% 285
2021
Q2
$708K Buy
5,231
+815
+18% +$107K 0.08% 274
2021
Q1
$599K Buy
4,416
+590
+15% +$88.3K 0.08% 270
2020
Q4
$539K Buy
3,826
+103
+3% +$13.2K 0.09% 235
2020
Q3
$441K Buy
+3,723
New +$417K 0.08% 243

Other funds holding XBI

PFG Advisors's XBI Position: Q3 2026 in Review

PFG Advisors opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 11,480 shares worth $1.81M. The stake represents 0.09% of the portfolio and ranks #257 among its holdings. This is a return to the name: PFG Advisors previously reported a position in XBI as recently as Q1 2025.

PFG Advisors first reported a position in XBI in Q3 2020 and has held it in 20 quarters since. The position peaked at $8.97M in Q3 2024. 963 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • PFG Advisors held 11,480 shares of State Street SPDR S&P Biotech ETF worth $1.81M as of Q3 2026.
  • State Street SPDR S&P Biotech ETF was a new PFG Advisors position in Q3 2026.
  • State Street SPDR S&P Biotech ETF made up 0.09% of PFG Advisors's portfolio in Q3 2026, its #257 holding.
  • PFG Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and has held it in 20 quarters since.
  • PFG Advisors's State Street SPDR S&P Biotech ETF position peaked at $8.97M in Q3 2024.
  • 963 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on PFG Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.